bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Rhythm Pharmaceuticals Inc. logo

    Rhythm Pharmaceuticals Inc.

    RYTM | NASDAQ
    Chart Builder DCF Calculator
    $98.48
    +$0.77 (+0.79%)
    Sep 21, 2026, 12:34 PM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $6.7B
    Enterprise Value
    $6.38B
    Beta
    1.97
    Average Volume
    747.21K
    Shares Outstanding (Diluted)
    68.59M
    Shares Change YoY
    7.71%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US76243J1051

    Price Performance

    Price Change 1M
    -16.8%
    Price Change 3M
    -3.6%
    Price Change 6M
    15.4%
    Price Change YTD
    -7.0%
    Price Change 1Y
    -0.8%
    Price Change 3Y
    319.2%
    Price Change 5Y
    652.2%
    1M CAGR (ann.)
    -12.8%
    1Y CAGR (ann.)
    1.7%
    5Y CAGR (ann.)
    49.7%
    All-Time CAGR
    14.1%

    Valuation

    PE Ratio
    -31.42
    Forward PE
    2,084.70
    PEG Ratio
    7.86
    Forward PEG
    0.40
    PS Ratio
    27.94
    Forward PS
    12.10
    PB Ratio
    30.84
    P/FCF Ratio
    -44.54
    P/Adj. FCF Ratio
    -25.70
    P/OCF Ratio
    -44.82
    EV/Sales
    26.57
    EV/EBIT
    -34.31
    EV/EBITDA
    -34.47
    EV/FCF
    -42.36
    Earnings Yield
    -3.2%
    FCF Yield
    -2.3%
    Adj. FCF Yield
    -3.9%

    Financial Health

    Net Cash
    $330.9M
    Total Debt
    $3.68M
    Cash & Short-Term Investments
    $330.9M
    Total Assets
    $437.27M
    Current Ratio
    3.45
    Quick Ratio
    3.20
    Debt / Equity Ratio
    0.02
    Debt / EBITDA
    -0.02
    Debt / FCF
    -0.02
    OCF / Debt
    -40.61
    Interest Coverage
    -10.86
    Altman Z-Score
    13.60
    Piotroski F-Score
    4

    Margins & Profitability

    Gross Profit Margin
    89.0%
    Operating Profit Margin
    -83.6%
    EBITDA Margin
    -77.0%
    Net Profit Margin
    -85.6%
    FCF Margin
    -62.7%
    Adj. FCF Margin
    -108.7%
    SBC / Revenue
    46.0%
    SBC Impact (per share)
    -73.3%

    Returns

    Return on Assets
    -47.0%
    Return on Equity
    -80.5%
    Return on Invested Capital
    -63.8%
    Return on Capital Employed
    -64.0%
    Return on Tangible Assets
    -47.5%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    76.3%
    Revenue CAGR 5Y
    278.5%
    Revenue CAGR 10Y
    42.6%
    EPS CAGR 3Y
    17.7%
    EPS CAGR 5Y
    3.1%
    EPS CAGR 10Y
    -6.2%
    FCF CAGR 3Y
    6.3%
    FCF CAGR 5Y
    6.9%
    FCF CAGR 10Y
    -10.7%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    22
    EPS Growth Next 3Y
    102.0%
    Revenue Growth Next 3Y
    74.3%
    Earnings Date
    Nov 2, 2026
    EPS Estimate (next Q)
    -$0.72
    EPS Growth Est (next Q)
    -11.9%
    Revenue Est (next Q)
    $84.52M
    Revenue Growth Est (next Q)
    64.8%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $143.83
    Price Target Upside
    47.2%

    Cash Flow

    Operating Cash Flow
    $-149.53M
    Free Cash Flow
    $-150.49M
    Adj. Free Cash Flow
    $-260.82M
    FCF Per Share
    -$2.19
    OCF Per Share
    -$2.18
    OCF/S Ratio
    -62.3%

    Income Statement

    Revenue
    $239.92M
    Gross Profit
    $213.53M
    Operating Income
    $-200.63M
    EBITDA
    $-184.97M
    Net Income
    $-205.35M
    EPS (Diluted)
    -$3.11
    Revenue / Employee
    $579.51K
    Profit / Employee
    $-496K
    Employees
    414

    © 2026 bestshares.com. All rights reserved.